- Home
- BDX
as 05-09-2025 3:31pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 58.9B | IPO Year: | 1962 |
| Target Price: | $246.88 | AVG Volume (30 days): | 3.4M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.16 | EPS Growth: | 14.07 |
| 52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 05-01-2025 |
| Revenue: | $20,867,000,000 | Revenue Growth: | 5.84% |
| Revenue Growth (this year): | 9.27% | Revenue Growth (next year): | 4.98% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Garrison Michael David | BDX | EVP & President, Medical | Apr 9 '25 | Sell | $197.28 | 479 | $94,497.12 | 4,887 | |
| Byrd Richard | BDX | EVP & President Interventional | Mar 18 '25 | Sell | $230.00 | 459 | $105,570.00 | 6,952 | |
| Byrd Richard | BDX | EVP & President Interventional | Mar 12 '25 | Sell | $224.91 | 1,940 | $436,325.40 | 6,952 | |
| SCOTT BERTRAM L | BDX | Director | Feb 12 '25 | Sell | $227.99 | 700 | $159,593.00 | 36,033 | |
| Henderson Jeffrey William | BDX | Director | Feb 10 '25 | Buy | $233.62 | 1,500 | $350,430.00 | 8,015 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 hours ago
The Strong Earnings Posted By Becton Dickinson (NYSE:BDX) Are A Good Indication Of The Strength Of The Business
StockStory
15 hours ago
3 Profitable Stocks with Questionable Fundamentals
Insider Monkey
2 days ago
Jim Cramer on Becton, Dickinson and Company (BDX): “A Shocking Miss for This Once-Reliable Med Tech Giant”
Simply Wall St.
3 days ago
Becton Dickinson (NYSE:BDX) Sees 18% Price Dip Over Last Week
MT Newswires
3 days ago
Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $196 From $280, Maintains Overweight Rating
Simply Wall St.
3 days ago
Becton Dickinson Second Quarter 2025 Earnings: Misses Expectations
Insider Monkey
5 days ago
Becton, Dickinson, and Company (BDX): Among the Best Falling Stocks to Buy According to Analysts
MT Newswires
7 days ago
Becton, Dickinson Shares Drop After Multiple Analyst Downgrades
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.